但遗传学界发生的革命 - 使科学家能够快速便宜地盘查癌症的受损基因 – 正激起对新一代精准用药的兴奋巨浪。
The world's largest cancer conference - a meeting of 30,000 doctors and scientists - has already heard how a precision approach is helping to beat cancer.
这次汇聚3万名医生和科学家的世界最大癌症会议,已经听到了精准治疗正在如何帮助战胜癌症。
Dr Maria Schwaederle, from the centre for personalised cancer therapy at the University of California, San Diego, has presented data on 346 highly experimental clinical trials involving 13,203 patients.
来自加州大学圣迭戈分校个体化癌症治疗中心的施瓦伊德勒博士,展示了对13203名患者所做的346次高度实验性的临床试验数据。
Of the studies, 58 used a precision approach…Cancers shrank in 31% of cases when a drug was matched to the tumour's weaknesses compared with just 5% of the time without.
研究中58人使用了精准治疗……当对肿瘤的薄弱之处使用匹配药物时,31%的病例出现了肿瘤萎缩,而未用匹配药物时只有5%。
And the time before the disease worsened increased from three months to nearly six months with precision medicine.
而且,使用精准治疗后,病情出现恶化的时间从3个月增加到了近6个月。
Dr Schwaederle said the findings were "striking" and praised the "breath-taking advances in our ability to perform genomics" that was revealing the inner workings of tumours.
【个体化癌症药物 新一代精准用药】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15